7/29/2020 9:14:43 AM
Sorrento Reports License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva
7/24/2020 9:04:20 AM
Sorrento Enters LoI To Acquire SmartPharm
7/20/2020 9:17:11 AM
Sorrento Therapeutics Receives FDA Clearance To Initiate Phase 2 Trial Of Abivertinib In Patients With COVID-19
5/26/2020 9:10:41 AM
Sorrento Therapeutics Receives FDA Clearance For Investigational New Drug Application For STI-6129
5/15/2020 11:03:28 AM
Sorrento Says Anti-SARS-CoV-2 Antibody, STI-1499, Shows 100% Inhibition Of SARS-CoV-2 Virus Infection; Stock Surges
5/8/2020 9:24:10 AM
Sorrento And Mount Sinai Health System To Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection
1/27/2020 7:06:19 AM
Sorrento Therapeutics Unanimously Rejects Recent Acquisition Proposal
1/10/2020 7:04:44 AM
Sorrento Therapeutics Gets Non-binding Proposal From A Private Equity Fund To Buy Shares Of The Company For Up To $7/Shr